Bronchobos, 375 mg capsules 30 pcs

Mucolytic drug. The action of the drug is due to the activation of sialyl transferase – an enzyme of the mucous membrane of the bronchi.

Normalizes the quantitative ratio of acidic and neutral sialocytes of the bronchial secretion, restores mucus viscosity and elasticity. Promotes the regeneration of the mucous membrane, normalizes its structure and activates the activity of the ciliated epithelium.

Restores the secretion of immunologically active IgA (specific protection) and the number of sulfhydryl groups of mucus components (nonspecific protection), improves mucociliary clearance.

Indications

Active ingredient

Composition

1 capsule contains:

Active substance:

carbocysteine 375.0 mg;

Ancillary substances:

Corn starch, 23 mg;

Magnesium stearate, 2 mg;

gelatin – 8 mg;

silicon dioxide colloid – 2 mg.

How to take, the dosage

Ingestion. Adults and adolescents over 15 years of age – 750 mg (2 capsules) 3 times a day.

After therapeutic effect is achieved, the daily dose is reduced to 1.5 g – 750 mg (2 capsules) 2 times a day.

The treatment should not be continued for more than 8-10 days without consulting a physician.

Interaction

Increases the effectiveness of glucocorticoid (mutually) and antibacterial therapy of infectious and inflammatory diseases of the upper and lower respiratory tract.

Potentiates the bronchodilator effect of theophylline.

The activity of carbocysteine is attenuated by anti-cough and atropine-like agents.

Special Instructions

In patients with a history of peptic ulcer disease of the stomach and duodenum, the dose of the drug should be reduced. Treatment can be combined with physiotherapeutic procedures.

The effect of the drug on the ability to drive vehicles and perform work requiring increased concentration and rapid psychomotor reactions. It has not been studied.

Contraindications

With caution when taking the drug in chronic glomerulonephritis (in anamnesis), gastric and duodenal ulcer (in anamnesis).

Side effects

Gastrointestinal disorders: sometimes nausea, vomiting, diarrhea and epigastric pain, gastrointestinal bleeding have been reported.

Hypersensitivity reactions: single cases of allergic reactions (skin itching, urticaria, exanthema, angioedema) have been reported.

Others: dizziness, weakness, malaise.

In patients with bronchial asthma and elderly patients, airway obstruction may occur.

Overdose

Symptoms: stomach pain, nausea, diarrhea.

Treatment: symptomatic.

Pregnancy use

In the second and third trimesters of pregnancy the drug is prescribed only when the estimated benefit to the mother exceeds the potential risk to the fetus.

If it is necessary to prescribe the drug during lactation, discontinuation of breastfeeding should be considered.

Similarities